Although inflammatory markers such as IL-6, IL-8, and TNF-α have been proven to be sensitive and reliable markers for the risk stratification of CI-AKI (19, 20), these test indicators usually cannot be obtained routinely or rapidly, limiting their application in clinical practice. The gene discussed is TNF; the disease is acute kidney injury.